Eton Pharmaceuticals Inc. (ETON)
NASDAQ: ETON
· Real-Time Price · USD
20.24
0.00 (0.00%)
At close: May 22, 2025, 3:59 PM
20.40
0.79%
Pre-market: May 23, 2025, 07:17 AM EDT
Eton Pharmaceuticals Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 |
|---|---|---|
| License Revenue | 500K | 5.5M |
| License Revenue Growth | -90.91% | n/a |
| Product Sales and Royalties Revenue | 38.51M | 26.14M |
| Product Sales and Royalties Revenue Growth | +47.31% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 9.17M | 6.72M | 5.29M | 5.59M | 5.16M | 4.58M | 4.34M | 4.67M | 5.34M | 4.35M | 4.17M | 5.26M | 4.93M | 3.82M | 3.33M | 3.27M | 4.06M | 3.8M | 3.43M | 2.92M | 2.61M | 2.43M | 1.62M | 1.91M | 1.59M | 1.18M | 830K | 990K | 1.69M | 2.94M | 1.21M | 681K |
| Selling, General, and Administrative Revenue Growth | +36.50% | +27.04% | -5.42% | +8.44% | +12.70% | +5.51% | -7.23% | -12.55% | +22.76% | +4.44% | -20.79% | +6.82% | +29.05% | +14.76% | +1.87% | -19.52% | +6.79% | +10.82% | +17.39% | +11.92% | +7.45% | +49.57% | -14.97% | +20.20% | +34.21% | +42.65% | -16.16% | -41.42% | -42.58% | +144.03% | +77.09% | n/a |
| Research and Development Revenue | 1.16M | -871K | 505K | 2.97M | 651K | 1.05M | 615K | 1.13M | 535K | 944K | 744K | 690K | 1.62M | 681K | 2.68M | 1.99M | 886K | 3.4M | 2.83M | 1.61M | 6.27M | 233K | 3.42M | 1.44M | 6.46M | 1.1M | 1.54M | 1.71M | 1.27M | 2.83M | 1.56M | 1.5M |
| Research and Development Revenue Growth | -233.30% | -272.48% | -83.00% | +356.22% | -37.82% | +70.24% | -45.33% | +110.28% | -43.33% | +26.88% | +7.83% | -57.35% | +137.59% | -74.57% | +34.57% | +124.60% | -73.95% | +20.35% | +75.64% | -74.33% | +2590.13% | -93.18% | +137.53% | -77.74% | +486.66% | -28.63% | -9.55% | +33.99% | -54.95% | +80.82% | +4.06% | n/a |